Dev Chatterjee And Reghu Balakrishnan

Stories by Dev Chatterjee And Reghu Balakrishnan

Foreign investors betting big on Indian consumers

Foreign investors betting big on Indian consumers

Rediff.com   6 May 2013

However, foreign investors have completely shunned the infrastructure sector.

PE directors wary of Companies Bill

PE directors wary of Companies Bill

Rediff.com   2 May 2013

PE firms are looking at various ways to protect their nominee directors.

Bharti may raise Rs 6,500 cr from foreign investors

Bharti may raise Rs 6,500 cr from foreign investors

Rediff.com   2 May 2013

Bharti was talking to Standard Chartered Bank and Citibank, among others, to manage the issue.

Why professionally-managed firms have reasons to smile

Why professionally-managed firms have reasons to smile

Rediff.com   28 Apr 2013

These companies gave annualised returns of 11% on an average in the last five years, while shareholders of family-owned companies saw 5% annualised erosion

Gold loan firms swing into action as prices fall

Gold loan firms swing into action as prices fall

Rediff.com   19 Apr 2013

These companies may recall loans in extreme cases; loan-to-value ratio stands at 60% but scrap value at 75%.

Sun eyes US skincare market

Sun eyes US skincare market

Rediff.com   18 Apr 2013

Last week, Sun's Israeli subsidiary, Taro Pharma, received the US Food and Drug Administration's approval for its New Drug Application to launch Topicort Topical Spray for the treatment of psoriasis.

Trusts can select, remove Tata Sons chairmen

Trusts can select, remove Tata Sons chairmen

Rediff.com   11 Apr 2013

These trusts hold 66 per cent stake in unlisted Tata Sons, the holding company of the $100-billion Tata group of companies.

BDR wrestles Big Pharma in patents match

BDR wrestles Big Pharma in patents match

Rediff.com   3 Apr 2013

Compulsory licence application filed for anti-cancer drug of Bristol Myers Squibb; more to come for four drugs.

The man behind Glivec hails verdict against Novartis

The man behind Glivec hails verdict against Novartis

Rediff.com   3 Apr 2013

Brian Druker, who invented the drug's molecule, says it would benefit patients in the short term.

Domestic pharma lauds apex court verdict

Domestic pharma lauds apex court verdict

Rediff.com   2 Apr 2013

Patients' lobbies cheer ruling on anti-cancer drug Glivec, as affordability and access to life-saving drugs get a leg-up.

Birla, Vedanta in race for Canada-based miner

Birla, Vedanta in race for Canada-based miner

Rediff.com   16 Mar 2013

The mining major is selling the company to reduce its debt.

Vedanta advised to acquire London's Cairn Energy

Vedanta advised to acquire London's Cairn Energy

Rediff.com   11 Mar 2013

Cairn Energy Plc, which has 50 production blocks across the world, holds 10% in Cairn India.

PSUs not floating in cash any more

PSUs not floating in cash any more

Rediff.com   8 Mar 2013

Most have seen decline in cash reserves and deterioration in financial ratios in recent years.

Backed by PEs, Pandit may invest in a new bank

Backed by PEs, Pandit may invest in a new bank

Rediff.com   7 Mar 2013

Citigroup's former chief executive officer, Vikram Pandit, might be joining the race to become a co-applicant for a banking licence in India.

After Budget, CEOs clamour for interest rate cut

After Budget, CEOs clamour for interest rate cut

Rediff.com   4 Mar 2013

An interest rate cut, at a time when demand was not showing any sign of revival, would boost sentiments, especially for interest-rate sensitives like the car and real estate sectors, which had been showing negative growth, a majority of the 15 CEOs polled by Business Standard said.

LG India gets tax demand on high advertising spend

LG India gets tax demand on high advertising spend

Rediff.com   25 Feb 2013

Tribunal ruling in I-T's favour may open floodgates to claims against other MNCs.

Investors run background checks on PE fund managers

Investors run background checks on PE fund managers

Rediff.com   22 Feb 2013

In some cases fake degrees and certificates were uncovered.

E-retailers stare at bleak funding scenario

E-retailers stare at bleak funding scenario

Rediff.com   21 Feb 2013

As funding from foreign private equity and venture capital firms is the lifeline for most online retailers, the restriction on foreign direct investment is threatening to block any fresh investment into the sector.

'Vedanta will double earnings to $12-13 bn in 2-3 years'

'Vedanta will double earnings to $12-13 bn in 2-3 years'

Rediff.com   19 Feb 2013

Interview with chairman, Vedanta.

Budget 2013: India Inc faces 'M&A tax'

Budget 2013: India Inc faces 'M&A tax'

Rediff.com   13 Feb 2013

Guarantees given to overseas arms under I-T scanner.